Johnson & Johnson JNJ
NYSE JNJ
$266.34 -0.74 (-0.28%)
As of: Sep 10, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Retained Earnings (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Retained Earnings came in at $171.7 billion in Q2 2026, up 3.81% year-over-year from $165.4 billion in Q2 2025, and up 1.48% quarter-over-quarter from $169.2 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Retained Earnings (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Retained Earnings across 18 years of filings, most recently posting $171.7 billion for Q2 2026.

  • In Q2 2026, Retained Earnings rose 3.81% year-over-year to $171.7 billion; the TTM figure through Jun 2026 stood at $171.7 billion (up 3.81% YoY), while the FY2025 annual figure was $169.0 billion, up 8.46% from the prior year.
  • Retained Earnings came in at $171.7 billion for Q2 2026 at Johnson & Johnson, up from $169.2 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $171.7 billion in Q2 2026 to a low of $123.1 billion in Q1 2022.
  • Average Retained Earnings over 5 years is $148.2 billion, with a median of $153.8 billion recorded in 2023.
  • Year-over-year, Retained Earnings gained 0.14% in 2023 and grew 23.14% in 2024.
  • Over 5 years, Retained Earnings stood at $127.9 billion in 2022, then gained by 20.27% to $153.8 billion in 2023, then advanced by 1.27% to $155.8 billion in 2024, then advanced by 8.46% to $169.0 billion in 2025, then climbed by 1.59% to $171.7 billion in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were $171.7 billion in Q2 2026, $169.2 billion in Q1 2026, and $169.0 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 171.67 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -17.33 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 40.86 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 112.09 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -4.00 Bn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1.10 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 9.16 Bn
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn 724.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 171.67 Bn
Mar 29, 2026 169.16 Bn
Dec 28, 2025 168.98 Bn
Sep 28, 2025 167.28 Bn
Jun 29, 2025 165.37 Bn
Mar 30, 2025 162.64 Bn
Dec 29, 2024 155.79 Bn
Sep 29, 2024 155.18 Bn
Jun 30, 2024 155.36 Bn
Mar 31, 2024 153.38 Bn
Dec 31, 2023 153.84 Bn
Oct 1, 2023 152.54 Bn
Jul 2, 2023 129.38 Bn
Apr 2, 2023 124.56 Bn
Jan 1, 2023 128.35 Bn
Oct 2, 2022 127.92 Bn
Jul 3, 2022 126.22 Bn
Apr 3, 2022 124.38 Bn
Jan 2, 2022 123.06 Bn
Oct 3, 2021 121.09 Bn